Literature DB >> 26135141

HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.

Haitao Wang1, Guanzhong Liu2, Dan Shen3, Huamao Ye3, Jinming Huang4, Li Jiao3, Yinghao Sun3.   

Abstract

HOXA1, a member of the HOX gene family, has been implicated in tumor progression. However, the role of HOXA1 in prostate cancer is not well-established. In the present study, we found that HOXA1 was highly expressed in prostate cancer cells. We then repressed the expression of HOXA1 by short hairpin RNA (shRNA) to investigate the function of HOXA1 in prostate cancer cells. Our in vitro data showed that knockdown of HOXA1 attenuated the growth, invasion and migration of prostate cancer DU-145 and PC-3 cells. Furthermore, knockdown of HOXA1 resulted in an increased E-cadherin level and decreased Snail and MMP-3 levels in the DU-145 cells. In addition, knockdown of HOXA1 inhibited activation of ERK1/2 and AKT in the DU-145 cells. Our in vivo data revealed that knockdown of HOXA1 suppressed the growth and metastasis of prostate cancer cells. Collectively, our findings suggest that HOXA1 is involved in the regulation of prostate cancer progression, including cell growth, migration, invasion and metastasis. Thus, downregulation of HOXA1 may be a novel approach for the treatment of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26135141     DOI: 10.3892/or.2015.4085

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  30 in total

1.  HOXB5 promotes retinoblastoma cell migration and invasion via ERK1/2 pathway-mediated MMPs production.

Authors:  Haiming Xu; Hailan Zhao; Jie Yu
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 2.  Prostate Organogenesis.

Authors:  Jeffrey C Francis; Amanda Swain
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

3.  Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.

Authors:  Li Chen; Ning Hu; Chao Wang; Hongmian Zhao; Yueli Gu
Journal:  Cell Cycle       Date:  2018-01-29       Impact factor: 4.534

Review 4.  Multiple roles of HOX proteins in Metastasis: Let me count the ways.

Authors:  Joy Jonkers; Priya Pai; Saraswati Sukumar
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

5.  MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3.

Authors:  Xiupeng Xu; Zhongyuan Bao; Yinlong Liu; Jing Ji; Ning Liu
Journal:  Cell Mol Neurobiol       Date:  2017-01-25       Impact factor: 5.046

6.  Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells.

Authors:  Hao Xu; Shangjun Wu; Xin Shen; Ding Wu; Zhenguo Qin; Hao Wang; Xiaogang Chen; Xiaoqing Sun
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

Review 7.  MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

8.  Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma.

Authors:  Hui Li; Xiaomin Wang; Mingjie Zhang; Mengjun Wang; Junjie Zhang; Shiyin Ma
Journal:  Front Mol Biosci       Date:  2021-03-08

9.  HOXB7 as a promising molecular marker for metastasis in cancers: a meta-analysis.

Authors:  Fang-Teng Liu; Yang-Xi Ou; Guan-Ping Zhang; Cheng Qiu; Hong-Liang Luo; Pei-Qian Zhu
Journal:  Onco Targets Ther       Date:  2016-05-06       Impact factor: 4.147

10.  Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.

Authors:  Chenwei Yuan; Xingwu Zhu; Yang Han; Chenlong Song; Chenchen Liu; Su Lu; Meng Zhang; Fudong Yu; Zhihai Peng; Chongzhi Zhou
Journal:  J Exp Clin Cancer Res       Date:  2016-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.